Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to improve child vaccination uptakes rates.

We are committed to improving vaccination uptake rates to fully protect children and the public from preventable diseases. It is vitally important that everyone has their recommended vaccinations, as they are the best way to help protect yourself and your family from these viruses that can cause serious harm.

The NHS Vaccination Strategy outlines the steps that we will take to improve uptake of our childhood vaccination programmes through investing in the digital infrastructure and data systems for vaccination programmes, delegating commissioning of services to integrated care boards (ICBs), and exploring new ways of using workforce and delivery networks to administer vaccinations that meet the needs of local communities. The strategy is available at the following link:

https://www.england.nhs.uk/long-read/nhs-vaccination-strategy/

In line with the strategy and with the Government’s commitment, children will receive vital vaccines more easily thanks to a new trial using health visitors to administer childhood immunisations. The initiative, outlined in our urgent and emergency improvement plan, will test having health visiting teams deliver flu vaccinations and other jabs to eligible children, making protection more accessible for underserved families across selected areas.

We are also updating the vaccination schedule from 1 January 2026 to offer the second dose of measles, mumps and rubella (MMR) vaccine at eighteen months old to give young children the best protection against measles, mumps and rubella. Any children who have missed this second dose of MMR can have it at their pre-school vaccinations, at the same time as their 4 in 1 booster. This change is expected to improve MMR vaccine uptake, as has been demonstrated in a number of London boroughs where this change has already been made, and better uptake will reduce the likelihood of measles outbreaks. This is in addition to schedule changes from 1 July 2025 to move the second dose of meningococcal B vaccination to 12 weeks of age to provide earlier protection.

To raise awareness of potential vaccination benefits and increase awareness of the programmes, the UK Health Security Agency (UKHSA) provides a comprehensive suite of resources, including information leaflets in multiple languages and accessible formats. UKHSA also provides comprehensive clinical guidance, including e-learning programmes and training, for healthcare professionals. These are available in print form and for download at the following link:

https://www.healthpublications.gov.uk/ArticleSearch.html

UKHSA also undertakes regular surveys of parents and adolescents to understand how their knowledge, beliefs and attitudes towards immunisation, vaccine safety, and disease severity influence their vaccine uptake decision-making. This information enables the resources to be revised and updated to meet the needs of those accessing vaccination services. Data on vaccination uptake is available at the following link:

https://www.gov.uk/government/collections/vaccine-uptake